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Study is valid and helps define
proper role of surveillance
Our publication is the first randomized controlled trial
that has studied the influence of flow (Qa) surveillance
on graft survival [1]. We share the disappointment of the
nephrology community that surveillance did not prolong
graft life.
Dr. Levine questions the validity of our study because
we did not apply decrease in Qa (Qa), and did not re-
strict Qa measurements to early in dialysis. Our observa-
tion that Qa does not improve prediction of thrombosis
[2] was confirmed by a second study that was reviewed
by two statisticians [3]. In addition, we have shown that
hemodynamic variation is so great that there is no value
in limiting measurements too early in dialysis [1]. More-
over, risk of thrombosis increases with ultrafiltration vol-
ume [3]. This indicates that hemodynamic state at the end
of dialysis influences thrombosis, suggesting that it may
be better to measure Qa late rather than early in dialysis.
Dr. Levine has restated criticisms made by Krivitski
and Gantela [4, 5] concerning our study that evaluated
accuracy of Qa in predicting thrombosis [2].
(1) They claimed our calculations had multiple errors
because a figure and a table did not have equal numbers of
false positives [4]. This difference was expected because
these two analyses did not include the same number of
grafts [2]. The only error was in calculating predictive ac-
curacy of Qa and Qa with the data in Table 1. Correction
yielded a lower predictive accuracy [6].
(2) They claimed that reanalysis of our data shows Qa
accurately predicts thrombosis [4]. Their analysis is not
valid because they only considered Qa; they excluded
grafts that thrombosed before Qa could be measured.
Inclusion of all grafts yields a poor predictive accuracy
(Table 1).
Table 1. Original data used to determine accuracy of Qa and Qa
(combined as either/or) in predicting thrombosis [2, 6]a
Negative test Positive test
Qa ≥ 600 mL/min and Qa < 600 mL/min or
Qa < 20% Qa ≥ 20%
Patient 30 9
Thrombosed 18 26
aSensitivity, 59%; false positive rate, 23%. Eighteen of 44 thrombosed grafts
did so without warning. Table includes 8 grafts that thrombosed before Qa
could be measured. Predictive accuracy was optimized by predicting outcome
within 1 month and measuring Qa over 3 months.
(3) They criticized our suggested guideline for ade-
quate predictive accuracy [5]. Actual predictive accuracy
was so poor that this criticism is irrelevant.
(4) They claimed we “have no basis for making any
conclusions” without doing a harm-benefit analysis [5].
They have not applied this criticism to studies that favor
Qa surveillance, and the information required to do such
an analysis is not available [6].
In conclusion, our surveillance study [1] was properly
designed, and our studies convincingly show that Qa is
an inaccurate predictor of thrombosis [2, 3, 6]. Only by
considering the results of such ongoing research can we
hope to define the proper role of surveillance.
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Markers of oxidative stress
in uremia
To the Editor: In their recent paper, Witko-Sarsat et al
[1] hypothesized that advanced oxidation protein prod-
ucts (AOPP) behave as mediators of inflammation. A
